FDA Approved: ENVARSUS XR — Original Application (Veloxis Pharmaceuticals, Inc)

View source ↗

Summary

ENVARSUS XR (tacrolimus) received FDA approval as an original application to prevent organ rejection in kidney transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Envarsus XR (Tacrolimus)

Snippet

ORIG AP for ENVARSUS XR (TACROLIMUS)